Similar articles

• New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.

  Jaggard MK, MacRae C, Ifeacho S, Robinson S, Tolley NS. Jaggard MK, et al. J Laryngol Otol. 2009 Jul;123(7):796-800. doi: 10.1017/S0022215108003472. Epub 2008 Sep 4. J Laryngol Otol. 2009. PMID: 18771606 Review.
• RET polymorphisms in codons 769 and 836 are not associated with predisposition to medullary thyroid carcinoma.

  Wiench M, Włoch J, Wygoda Z, Gubała E, Oczko M, Pawlaczek A, Kula D, Lange D, Jarzab B. Wiench M, et al. Cancer Detect Prev. 2004;28(4):231-6. doi: 10.1016/j.cdp.2004.04.002. Cancer Detect Prev. 2004. PMID: 15350625
• Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.

  Moore SW, Appfelstaedt J, Zaahl MG. Moore SW, et al. J Pediatr Surg. 2007 Feb;42(2):326-32. doi: 10.1016/j.jpedsurg.2006.10.005. J Pediatr Surg. 2007. PMID: 17270543
• Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.

  Bugalho MJ, Domingues R, Santos JR, Catarino AL, Sobrinho L. Bugalho MJ, et al. Surgery. 2007 Jan;141(1):90-5. doi: 10.1016/j.surg.2006.03.025. Epub 2006 Jul 31. Surgery. 2007. PMID: 17188172
• DNA-based window of opportunity for curative pre-emptive therapy of hereditary medullary thyroid cancer.

  Machens A, Dralle H. Machens A, et al. Surgery. 2006 Mar;139(3):279-82. doi: 10.1016/j.surg.2005.07.034. Surgery. 2006. PMID: 16546489 Review. No abstract available.